An increased permeability of the mitochondrial inner membrane, the permeability transition, is a key event in cell death (1). The permeability transition is due to opening of the permeability transition pore (PTP), 2 a high conductance channel of unknown molecular structure that is modulated by cyclophilin D (CyP-D) (2). The PTP can be desensitized by the CyP inhibitor cyclosporin A (CsA) (3-6) or by ablation of CyP-D (7-10), and CyP-D-null mice are strikingly resistant to ischemic heart (7, 9) and brain (10) damage and to experimental autoimmune encephalomyelitis (11). Treatment with CsA cured a mouse model of collagen VI muscular dystrophy through PTP inhibition (12) and normalized mitochondrial function and apoptosis in patients with collagen VI muscular dystrophies (13,14). CyP-D ablation led to recovery from muscle pathology in other mouse models of muscular dystrophy, suggesting that PTP opening may play a role in more than one form of myopathy (15). The mechanism through which treatment with CsA and lack of CyP-D affects the PTP remains unsolved, however; and the extent to which it is possible to apply results obtained from in vitro studies to the status of the PTP in situ remains an open question (2). Here, we show that ablation of CyP-D or treatment with CsA does not directly cause PTP inhibition, but rather unmasks an inhibitory site for P i . Indeed, we found that the inhibitory effects of CsA and of CyP-D ablation disappeared when P i was replaced by vanadate (V i ), arsenate (As i ), or bicarbonate and that, in the absence of P i , the PTP sensitivity to Ca 2ϩ and oxidative stress was identical in wild-type and CyP-D-null mitochondria. Our results indicate that the PTP is not sensitive to CsA or to CyP-D ablation unless P i is present.
EXPERIMENTAL PROCEDURESMitochondria were isolated from the livers of C57BL/6J (wild-type) and Ppif Ϫ/Ϫ C57BL/6J (CyP-D-null) mice by standard differential centrifugation. The properties of the CyP-Dnull mitochondria have been described elsewhere (8). Protein concentration was determined using the biuret method, and the mitochondrial suspension was kept on ice and used within 4 h of preparation.The incubation medium contained 120 mM KCl, 10 mM Tris/MOPS, 5 mM Tris glutamate, 2.5 mM Tris malate, 20 M Tris/EGTA, and P i , V i , or As i (as specified in the figure legends) at pH 7.4. For all measurements, the concentration of mitochondrial protein was 0.5 mg/ml at 25°C. Oxygen consumption was measured with a Clark-type oxygen electrode in a closed 2-ml vessel equipped with magnetic stirring. Membrane potential was estimated based on fluorescence quenching of rhodamine 123 (16) in 2-ml stirred cuvettes with a PerkinElmer Life Sciences LS50B spectrofluorometer (0.3 M rhodamine 123; excitation and emission wavelengths of 503 and 525 nm, respectively). The mitochondrial calcium retention capacity (CRC) (17) was determined in medium supplemented with 1 M Calcium Green-5N (Molecular Probes) either with the PerkinElmer Life Sciences spectrofluorometer (excitation and emission wa...